iShares TecDAX® UCITS ETF (DE) EUR is a equity ETF from iShares tracking the TecDAX index through physical replication. Domiciled in Germany and launched in 2001, the fund manages about 608 M € and charges a TER of 0.51% — 51 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
iShares TecDAX® UCITS ETF (DE) EUR competes with 1 other products on the same index (TecDAX): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.51% against a group median of 0.51%. It has been listed since 2001, 25 years of track record.
On a €10,000 investment the TER costs 51 € a year. The cheapest of the group is iShares TecDAX® UCITS ETF (DE) Dist at 0.51%, or 51 € on the same amount: a difference of 0 € every year, roughly 0 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 79.5% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Germany, which determines the tax treatment of income received by the fund and the supervisory authority.
| Infineon Technologies AG | 16.2% |
| SAP SE | 14.6% |
| Deutsche Telekom AG | 13.1% |
| Siemens Healthineers AG | 10.1% |
| Qiagen NV | 5.6% |
| AIXTRON SE | 4.8% |
| Nordex SE | 4.6% |
| Sartorius AG Participating Preferred | 4.6% |
| Hensoldt AG | 3.2% |
| Nemetschek AG O.N. | 2.7% |
| XETRA | EXS2 | EUR |
| Francoforte | EXS2 | EUR |
| SIX Swiss Exchange | TDXPEX | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.